Features | Partner Sites | Information | LinkXpress
Sign In
Shuenn Bao Shing Corporation
SOREDEX
Ampronix

Protection Device Minimizes Brain Damage in Cardiovascular Procedures

By HospiMedica International staff writers
Posted on 02 Oct 2013
Image: The TriGuard Cerebral Protection Device (Photo courtesy of Keystone Heart).
Image: The TriGuard Cerebral Protection Device (Photo courtesy of Keystone Heart).
An innovative cerebral protection device (CPD) reduces the volume of new brain lesions, especially during protected transcatheter aortic valve replacement (TAVR).

The TriGuard CPD is a Nitinol mesh embolic debris deflection device designed to cover all three aortic cerebral branches to minimize the risk of brain damage during cardiovascular (CV) procedures, and accommodates most anatomical variations of the aortic arch. The Nitinol frame and mesh are designed to be flexible and atraumatic, yet robust and sturdy, thus providing simple placement and retrieval.

The device is placed via one of two femoral artery access ports typically used in TAVR, eliminating the need for a third puncture site, and deploys rapidly, self-positioning through a 3-mm catheter. Studies have shown that compared with historical data on unprotected TAVR procedures, use of the TriGuard CPD decreased maximum total lesion volume by 95%, while average total lesion volume was 57% smaller, when compared with historical references. The TriGuard Cerebral Protection Device is a product of Keystone Heart (Caesarea, Israel), and has received the European community CE marking of approval.

“Cerebral function is the essence of quality of life. Its preservation throughout medical procedures is a key component to procedural success and patient care. TriGuard is the most sophisticated cerebral embolic protection device currently available,” said Andreas Baumbach, MD, consultant cardiologist at University Hospitals Bristol (United Kingdom). “The device has the potential to become a routine preventive measure in TAVR and other cardiovascular procedures associated with embolic lesions.”

Cerebral emboli are commonly associated with left-sided cardiac procedures. During CV procedures, debris from the aortic valve, ascending aorta, and other sources may embolize and cause cerebral infarction. Cerebral damage may not be clinically evident after CV procedures and can take months or years for symptoms to manifest, often as devastating stroke, dementia, and cognitive decline. Embolic brain lesions can be objectively and consistently detected by diffusion-weighted magnetic resonance imaging (DW-MRI).

Related Links:

Keystone Heart
University Hospitals Bristol



Anetic Aid
CardioComm Solutions
Dunlee

Channels

Critical Care

view channel
Image: Solid microneedles coated with Bevacizumab (syringe for scale) (Photo courtesy of the Georgia Institute of Technology).

Tiny Needles Reshape Major Eye Disease Treatment

Novel microneedles allow dramatic dose sparing when compared to subconjunctival and topical administration of drugs directly into the eye. Developed by researchers at the Georgia Institute of Technology... Read more

Women's Health

view channel

Women with PTSD Face Higher Pregnancy Risk

Suffering from post-traumatic stress disorder (PTSD) significantly increases a pregnant woman's risk of premature birth, according to a new study. Researchers at Stanford University (CA, USA) conducted a study to identify antenatal PTSD status and spontaneous preterm delivery in a retrospective cohort (2000-2012).... Read more

Business

view channel

Global Wound Care Market Rife With Opportunity

Strong relationships with end users and an effective post sales service strategy must be a priority for wound care companies. These are the latest findings of Frost & Sullivan (Frost; London, United Kingdom), an international market research firm. The global wound care market is at a growth stage, driven by the increasingly... Read more
 

Events

26 Nov 2014 - 28 Nov 2014
01 Dec 2014 - 05 Dec 2014
Copyright © 2000-2014 Globetech Media. All rights reserved.